Know which market to enter first — and why.
Clarify target markets, development order and regulatory pathways before resources become locked into the wrong sequence.
Explore the pathwayAI-DRIVEN GLOBAL DEVELOPMENT & MARKET ACCESS
Make the nextmarket a clearerdecision.
Hope Focus connects regulatory intelligence, evidence strategy, clinical and real-world development, quality readiness and cross-border delivery into one accountable programme.
From Evidence to Access — Across Markets.
HOPE FOCUS / MARKET ACCESS
Your next market,
mapped.
Explore the three decisions along your route.
CHINA → GLOBAL / ROUTE
Which market should come first?
Compare market pathways against your product, intended use and existing evidence.
YOUR OUTPUTA prioritised market & pathway plan
01One entry pointfor complex programmes
02One integrated planfrom product to market
03One accountable teamwith governed partners
THE PROBLEM WORTH SOLVING
Global development should feel less fragmented.
The hard part is rarely a single regulatory question. It is keeping product decisions, evidence, quality, clinical work, partners and market timing aligned.
Turn existing data into reusable evidence.
Identify evidence gaps across clinical, RWE, CMC, quality and technical documentation — then design the bridge.
See the evidence layerMove from advice to accountable execution.
Bring the right specialist partners into one plan, with clear roles, milestones and independent conformity decisions.
Understand the modelTWO DIRECTIONS. ONE OPERATING MODEL.
Built for China ↔ Global journeys.
CHINA → GLOBAL
Help Chinese innovation move with confidence.
Global development order, market-specific pathways, evidence reuse, quality readiness and coordinated specialist delivery.
PharmaceuticalsMedical devices & IVDSaMD / AI-enabled devicesCombination products
Plan the next market GLOBAL → CHINA
Help global innovation reach China with evidence.
China market-entry feasibility, Lecheng pathways, RWD/RWE, local clinical strategy and coordinated CDE/CMDE readiness.
China entry assessmentLecheng & RWE pathwaysClinical & evidence planningLocal partner orchestration
Assess China readiness THE DIGITAL BACKBONE
Intelligence that stays connected to delivery.
Three digital capabilities make the programme visible, traceable and easier to govern — without pretending that AI replaces expert judgement.
01
RegAI.live
Regulatory intelligenceAI-native regulatory and registration intelligence organised around product, market, pathway, evidence and communication nodes.
↗02
Clinical & Evidence
Digital platformConnect clinical, real-world, data quality and evidence operations into a traceable chain from collection to submission readiness.
↗03
Global Readiness
& PMO toolkitProduct and pipeline diagnostics, evidence-gap mapping, partner coordination, milestone control and risk visibility in one working model.
↗HOW WE WORK
A clearer path from product judgement to market access.
One entry point. One integrated global development plan. One accountable project team.
See the operating model01
Assess & define
Product, pathway, target market and evidence-gap diagnosis.
02
Build the evidence
Clinical/RWE, CMC, technical documents, quality and data workstreams.
03
Orchestrate & deliver
Governed partners, regulatory communication preparation and PMO.
04
Access & follow through
Submission and certification readiness, lifecycle support and next-market expansion.
HUMAN-ACCOUNTABLE BY DESIGN
Confidence is built on clear boundaries.
AI and digital tools support regulatory intelligence, evidence planning, clinical research and project coordination. They do not replace expert judgement, regulatory review or independent conformity assessment.
Source-level traceabilityHuman review & sign-offIndependent assessmentNo promise of approval or timelines
READY WHEN YOU ARE
Start with the right path before you scale the programme.
Share a product, pipeline or market question. We will help frame the next useful decision.